Lyra Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LYRA and buy or sell other stocks, ETFs, and their options commission-free!About LYRA
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases.
CEOMaria Palasis
CEOMaria Palasis
Employees30
Employees30
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2005
Founded2005
Employees30
Employees30
LYRA Key Statistics
Market cap33.46M
Market cap33.46M
Price-Earnings ratio-3.62
Price-Earnings ratio-3.62
Dividend yield—
Dividend yield—
Average volume10.06M
Average volume10.06M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.344
52 Week high$0.344
52 Week low$0.082
52 Week low$0.082
Stock Snapshot
As of today, Lyra Therapeutics(LYRA) shares are valued at $0.50. The company's market cap stands at 33.46M, with a P/E ratio of -3.62.
Lyra Therapeutics(LYRA) stock opened on 2026-03-18 at —. The price climbed to — and dipped to —.
Lyra Therapeutics(LYRA) shares are trading with a volume of 0, against a daily average of 10.06M.
In the last year, Lyra Therapeutics(LYRA) shares hit a 52-week high of $0.34 and a 52-week low of $0.08.
In the last year, Lyra Therapeutics(LYRA) shares hit a 52-week high of $0.34 and a 52-week low of $0.08.
People also own
Based on the portfolios of people who own LYRA. This list is generated using Robinhood data, and it’s not a recommendation.